We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/4/2018 14:11 | @Monty You cannot compare the AbbVie bid with the situation now. Shire has since bought NPS and Baxalta. So a lot more assets but also a lot more debt. The problem right now is the market is essentially ignoring any value at all from Baxalta. | romeike | |
19/4/2018 14:11 | Heading up nicely now to break 4000 again | ernestsyngen | |
19/4/2018 13:58 | chris Agree. | montyhedge | |
19/4/2018 13:52 | Not going to happen by the look of it. Any other bidder would obviously wait for the shareprice to fall back now after the offer period lapses on 25th april. Sun lounger in the garden now ;-) | philanderer | |
19/4/2018 13:51 | IMO - poor that SHP did not reveal any of the approaches before now but I think Takeda is being cautious and prudent and SHP's language looks like they want to do a deal and why not with fair cash and lots of the company going forward | chris79 | |
19/4/2018 13:51 | Strange share price reaction from the market which tends to support Monty's view on the required price mix. Still think that we have a long way to go on this one. IMO 50%+ probability that at least one more bidding party will join the game. Shire in different hands will tilt the market in a direction that at least one of the other big boys won't feel comfortable with. At the very least they will want to make sure that any takeover by Takeda is at the "wrong" price! | ygor705 | |
19/4/2018 13:49 | I am happy with 4500p, to invest money in other shares. | demo trader | |
19/4/2018 13:48 | To clear up any misunderstanding on the part of some posters, AbbVie's final bid for shire in 2014 was 54 billion US dollars which at the time was equivalent to 34 billion pounds. | badwood | |
19/4/2018 13:46 | Offer was made April 12 and we hear about it now?!! | mbmiah | |
19/4/2018 13:45 | Bloomberg said this may bring one of the other pharma giants to come in. For me Takeda £55 cash and shares or £50 pure cash. I reckon AbbVie will come back. All good fun chaps. | montyhedge | |
19/4/2018 13:45 | Interesting when the US opens...... | soundbuy | |
19/4/2018 13:41 | Tricky.Question is,how high can Takeda go without compromising its credit rating and can Takeda go high enough to win Shire approval.I am not sure that Takeda can afford Shire and they won't make a hostile bid. | steeplejack | |
19/4/2018 13:33 | Passing shot, if they are offering shares and cash must be £55 or £50 pure cash, £46.50 no good. | montyhedge | |
19/4/2018 13:32 | Can see this holding way above 4000 by end of day if not 4200 | ernestsyngen | |
19/4/2018 13:31 | Hopefully this will kick off a bidding war, Takeda, AbbVie, Amgen and a few others could do it. | montyhedge | |
19/4/2018 13:29 | Holding from early £30’s patience required. Bought a load of (MARS) ahead of warmer weather, World Cup footie, got in at 104p, drinks sales will start pouring in literally dyor as usual | ny boy | |
19/4/2018 13:28 | I think £50 cash would be acceptable from the large shareholders. | montyhedge | |
19/4/2018 13:25 | Mike van Dulken Verified account @Accendo_Mike 37% cash / 63% Takeda shares not doing it for Shire Takeda confirms that on April 12 it made a revised proposal to the Board of Shire to acquire the entire issued and to be issued share capital of Shire for a price equivalent to GBP46.50 per share, comprised of GBP17.75 in cash (to be paid in US$) and GBP28.75 of new Takeda shares Shire has rejected proposal. Discussions between parties regarding potential offer ongoing; Takeda and Board reiterate it will remain disciplined with respect to terms of any offer; intends to maintain well-established dividend policy and investment grade credit rating | philanderer | |
19/4/2018 13:24 | AbbVie bid £53 and nearly done deal, Takeda £46.50 taking the mickey. Surely now £55. | montyhedge | |
19/4/2018 13:22 | HIGH 4054p, NOW 3882p | demo trader | |
19/4/2018 13:21 | We want AbbVie to come back, £53 was nearly done, then the tax rules came in. Trump could change things perhaps? | montyhedge | |
19/4/2018 13:21 | RNS was out at 13.04 | soundbuy | |
19/4/2018 13:20 | That Takeda offer was also made before the Oncology deal was announced. I don't know if that changes anything and means they could offer more cash. | billytkid2 | |
19/4/2018 13:20 | fiquant@fiquant 11 minutes ago SHIRE PLC - TAKEDA was subsequently notified that board of Shire had rejected it's proposal | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions